Posts by MVision Team

MVision AI Secures €2.8M Business Finland R&D Funding to Advance Radiotherapy Innovation
HELSINKI, June 2025 — MVision AI, a provider of cloud-based AI solutions for radiotherapy planning, has secured a €2.8 million loan from Business Finland R&D.…
Case Study: SLRON’s Integration of MVision AI in Radiotherapy Planning and Clinical Training
Overview St. Luke’s Radiation Oncology Network (SLRON) is Ireland’s largest radiotherapy provider and one of the largest centres in Europe. It treats over 5,500 patients…
SLRON’s AI Journey in Radiotherapy: An Interview with Ciarán Malone
Ciarán Malone is a medical physicist with over a decade of experience at St. Luke’s Radiation Oncology Network (SLRON) in Dublin. He is also a…
Guiding Science with Purpose: MVision AI Welcomes Gregory Bolard as New CSO
Helsinki, June 2025 – MVision AI has named Gregory Bolard as its new Chief Scientific Officer, marking a key step in the company’s ongoing development…
MVision AI’s Contour+ Receives Market Approval in Morocco
Helsinki, June 2025 — MVision AI is pleased to announce that Contour+, its AI-powered auto-contouring software for radiation therapy, has received market approval for clinical…
AI-Powered Dose Planning: Reducing Delays and Enhancing Quality in Radiation Oncology
Time is one of the most valuable resources, both for radiotherapy patients and healthcare professionals. For most cancer patients, short delays in the start of…
What’s the Difference Between Chemotherapy, Radiotherapy, and Immunotherapy?
In cancer treatment, terms like chemotherapy, radiotherapy, and immunotherapy are often used interchangeably by the public. However, they represent fundamentally different approaches to fighting cancer.…
AI in Bladder Cancer Radiotherapy Planning
May is Bladder Cancer Awareness Month, a time dedicated to raising global awareness about one of the most common and impactful urological cancers. It offers…
MVision AI’s Contour+ Approved for Clinical Use in Singapore
Helsinki, May 2025 — MVision AI announces that Contour+, its AI-based auto-contouring software for radiation therapy, has received market approval for clinical use in Singapore.…
MVision AI’s Contour+ Receives Market Clearance in the United Arab Emirates
HELSINKI, Finland – April 2025 — Contour+, MVision AI’s AI-powered auto-contouring software, has received market clearance from the United Arab Emirates Ministry of Health and…